Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
BeOne Medicines AG
NASDAQ:ONC
BeOne Medicines AG
NASDAQ:ONC
Price:
370.33
USD
-0.33%
Market Cap:
$516.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
BeOne Medicines AG
NASDAQ:ONC
|
CH |
Wall St Price Targets
ONC Price Forecast
Based on 8 analysts
Based on 8 analysts
+43% Upside
from
$370.33
today
BeOne Medicines AG (ONC)’s 12-month stock price forecast through October 2027 has a consensus target of $529.46, implying 43% upside. The forecast is based on price targets from 8 Wall Street analysts.
ONC Analyst Rating
Based on 27 analysts
Based on 27 analysts
Analysts rate ONC Strong buy, with 26 of 27 recommending Buy or Strong buy.
BeOne Medicines AG Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ONC's stock price target?
Price Target
529.46
USD
529.46
USD
According to Wall Street analysts, the average 1-year price target for ONC is 529.46 USD with a low forecast of 441.87 USD and a high forecast of 682.59 USD.
What is the Revenue forecast for BeOne Medicines AG?
Projected CAGR
11%
11%
Over the last 6 years, the compound annual growth rate for Revenue has been 53%. The projected CAGR for the next 8 years is 11%.
What is the Gross Profit forecast for BeOne Medicines AG?
Projected CAGR
61%
61%
Over the last 6 years, the compound annual growth rate for Gross Profit has been 54%. The projected CAGR for the next -3 years is 61%.
What is the Operating Income forecast for BeOne Medicines AG?
Projected CAGR
33%
33%
The compound annual growth rate for Operating Income over the next 8 years is 33%.
What is the Pre-Tax Income forecast for BeOne Medicines AG?
Projected CAGR
73%
73%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 73%.
What is the Net Income forecast for BeOne Medicines AG?
Projected CAGR
45%
45%
The compound annual growth rate for Net Income over the next 8 years is 45%.